VapBCs, virulence-associated proteins, are the most abundant type II toxin-antitoxin (TA) systems in prokaryotes. Under normal conditions, toxin and antitoxin interact to form a heterooctameric complex, which upon binding to operator sites, inhibits their own expression. Under stress conditions, the VapB antitoxin is degraded by cellular proteases to release a free VapC toxin, which in turn inhibits cell growth mainly by targeting protein translation. However, the intermediate steps involved in the assembly of the heterooctameric complex have not been resolved. Here, we report a 1.75
VapBCs, virulence-associated proteins, are the most abundant type II toxin-antitoxin (TA) systems in prokaryotes. Under normal conditions, toxin and antitoxin interact to form a heterooctameric complex, which upon binding to operator sites, inhibits their own expression. Under stress conditions, the VapB antitoxin is degraded by cellular proteases to release a free VapC toxin, which in turn inhibits cell growth mainly by targeting protein translation. However, the intermediate steps involved in the assembly of the heterooctameric complex have not been resolved. Here, we report a 1.75
A resolution crystal structure of VapC20, a Sarcin-Ricin loop cleaving toxin from type II TA system of Mycobacterium tuberculosis. Using analytical ultracentrifugation (AUC) studies, we show that VapC20 exists as a homodimer in solution. The structural analysis of VapC homologs further suggests that VapCs form homodimers. We demonstrate that VapC20 is an obligate homodimer, and its self-association is critical for its folding and activity. Surface plasmon resonance experiments suggest that VapC20 interacts with its cognate antitoxin VapB20 to form a stable complex with nanomolar affinity. A high association rate coupled with a very slow dissociation rate ensures minimal toxicity under normal growth conditions. AUC studies reveal that VapB20 also exists as a homodimer in solution and further associates with VapC20 dimers to form heterotetramers and heterooctamers in a concentration-dependent manner. The results presented here provide valuable insights into the assembly of VapBC family of toxins which is essential for their function and regulation.
Introduction
Over the course of survival in numerous nonfavorable conditions like nutrient depletion, hypoxia, temperature variability, and other environmental assaults, microbes have evolved genetic system that provides enormous potential for survival [1, 2] . Mycobacterium tuberculosis (Mtb) is a highly successful intracellular pathogen with an ability to persist in human granulomatous lesions from years to decades [3] . The treatment and eradication of persistent bacteria in the host poses a great challenge in the field of TB chemotherapy. Various regulatory proteins and signaling molecules such as (p)ppGpp, toxin-antitoxin (TA), sigma factors, CarD, RbpA, RelE, polyP are known to contribute to Mtb stress adaptation and bacterial persistence [4] [5] [6] [7] [8] .
Toxin-antitoxin systems comprise of two components, a Toxin with deleterious activity, and, an Antitoxin needed for neutralization of toxin's activity. TA system was first discovered in the plasmid referred to as an addiction molecule that conferred stability/plasmid maintenance in bacteria [9] . These TA modules have been implicated in the growing list of functions including multidrug tolerance [8, 10] , persistence, stress survival, biofilm formation, virulence, and pathogenesis [11, 12] . TA loci have been broadly classified into six types based on the mode and nature of the neutralizing antitoxin [13] . The antitoxins in these TA systems can be either proteinaceous or RNA in nature, and the toxins are always proteinaceous [14] . Among several known type II TA systems, virulence-associated proteins (VapBC) are the most abundant TA modules present in prokaryotes [15] . VapB and VapC constitute an operon that encodes for the antitoxin and toxin, respectively [16] . Mtb genome codes for~88 putative type II TA systems, which belong to VapBC, MazEF, RelBE, HigBA, ParDE, and other TA families [17] . More than half (48 members) of these TA systems belong to VapBC family and is the largest repertoire reported in any pathogen till date [18] . Mycobacterium smegmatis, a closely related nonpathogenic mycobacterium, has only one functional VapBC module and hence it is speculated that VapBC TA modules may have a possible role in Mtb stress adaptation and pathogenesis [18] . The VapC toxins are sequence-specific ribonucleases and cleave either Sarcin-Ricin loop (SRL) or tRNAs or mRNAs [19] [20] [21] [22] . In Mtb, only VapC20 and VapC26 have been reported to cleave SRL region in the 23S ribosomal RNA [20, 23] . Currently, extensive research is being carried out to understand the role of TA systems in bacterial physiology and virulence [10, 12, 24] .
The antitoxin belonging to Type II TA systems is proteinaceous in nature and its C-terminus interacts with the toxin, occluding the active site, thereby resulting in its neutralization [25] [26] [27] [28] [29] . The N-terminal domain of the two antitoxin molecules self-associates to form a dimer and adopts either ribbon-helix-helix or helix-turn-helix or AbrB or PhD/YefM DNAbinding domain architecture and binds the operator region [30, 31] . Under normal conditions, the TA complex binds to the operator region and negatively regulates its own expression [32, 33] . However, under stress conditions, the proteolytic cleavage of antitoxins occurs in a (p)ppGpp-dependent manner releasing the active toxin which causes growth inhibition and aids stress adaptation [4] . Proteolytic cleavage of antitoxin also results in destabilizing inhibitory complex which in turns leads to overexpression of TA operon [34] . It is well established that heterooctameric complex of VapBCs, where a toxin bridges the antitoxin dimers, has two distinct DNA-binding domains that mediate interaction with two operator sites [16, 27] . Though several crystal structures of VapC and VapBC proteins are available, the in solution oligomeric state of the toxins and antitoxins have not been extensively studied. Moreover, there is no study reporting the oligomeric transitions happening during the assembly of the functional heterooctameric TA complex. Based on the crystal structures, some VapC homologs have been proposed to exist as homodimers [26] [27] [28] [29] . But, the role of dimerization in toxin activity or coexistence of monomer/dimer population of toxin in solution has not been demonstrated.
Here, we are reporting the crystal structure of Mtb VapC20 (Rv2549c), a SRL cleaving toxin, at 1.75 A resolution. Using biophysical and biochemical studies, we demonstrate the importance of VapC20 homodimerization in protein solubility and activity. Using surface plasmon resonance experiments, we show that VapC20 interacts with VapB20 (Rv2550c) to form a stable complex with nanomolar affinity. We performed analytical ultracentrifugation (AUC) studies to resolve oligomeric states of VapC20, VapB20 and VapBC20 complex in solution. Based on the structural, biophysical and functional studies presented here, we propose a plausible model for the assembly of the functional heterooctameric complex.
Results

Crystal structure of VapC20
VapC20 is one of the few PIN-domain toxins where the target RNA substrate has been characterized. So, to understand the molecular details of VapC20, we solved the crystal structure at 1.75 A resolution. Both, VapC20 and VapC20 D5A point variant crystallized readily and diffracted well. Initial attempts to solve the crystal structure of VapC20 using molecular replacement did not yield any useful results despite trying several known VapC structures as the template. We also performed several heavy metal soaking experiments, but again we could not solve the structure. Finally, we were able to solve the structure using SeMet substituted VapC20 D5A using the Se-SAD method. VapC20 crystallized in P2 1 2 1 2 1 space group with two molecules related by nearly 2-fold symmetry in an asymmetric unit. The data collection and refinement statistics are provided in Table 1 . Both chains A and B of VapC20 toxin were structurally similar and superimposed well with root mean square deviation (r.m.s.d.) of about 0.3 A over 130 aligned Ca atoms. All the residues corresponding to the toxin region, except the last terminal residue Glu131, could be resolved well in the electron density. The structure of VapC20 revealed PINdomain fold with the canonical a/b/a sandwich comprising four parallel b-strands flanked by seven a-helices resulting in a topology of b1a1a2b2a3a 4b3a5a6b4a7 (Fig. 1A and 1B) . The catalytically conserved residues Asp5, Glu43, and Asp98 in the PIN domain superimposed well with the other known VapC homologs ( Fig. 1C and 1D ). In the VapC20 crystal structure, we did not observe electron density for the Mg 2+ ions. The other highly conserved Asp117, present in the loop region connecting b4 and a7, did not superimpose well ( Fig. 1C and 1D ). In Mtb VapC15, this structurally equivalent residue coordinate additional Mn 2+ ion and has been speculated to play a major role in catalysis [26] . Further, to identify structural homologs of VapC20, we performed the search using DALI server [35] . The PIN-domain ribonucleases were among the top hits returned by the server. The closest structural homologs based on the Z score are given in Table 2 .
While the overall fold is conserved, there are significant differences in the architecture of the active site pocket, antitoxin binding grooves and the overall charge distribution in VapC toxins (Fig. 1C & Fig. 2 ). The C-terminal region (terminal 10-15 residues) shows structural variations among different VapC structures [36] . In VapC20, the C-terminal seven residues are well resolved in electron density but do not adopt any secondary structure. Also, two arginine residues Arg50, [37] . ConSurf analysis provides the visual representation of the conservation of the amino acids mapped on to the protein structure based on the phylogenetic relations between homologous sequences. We performed multiple sequence alignments of all the 47 VapCs using Jalview [38] . VapC20 coordinate file was used for structural mapping. As anticipated, all the four negatively charged residues (classical PINdomain feature) in the active site pocket are highly conserved (Fig. 1D) . Interestingly, residues forming the protein core also show high conservation suggesting that these residues may be required for maintaining the PIN-domain fold. The crystal structure of VapC20 is comparable to known VapC structures with only subtle changes in the active site architecture and electrostatic potential (Fig. 2) . Recently, Kang et al. [29] reported the crystal structure of Mtb VapBC26. Although single chains of both the VapC20 and VapC26 toxins superimpose well (Fig. 3A ), significant differences were observed when both toxins were superposed as dimers (Fig. 3B) . While the PIN-domain architecture is well conserved, there are differences in the relative orientation of the monomers in the dimers suggesting differences in the mode of self-association ( Fig. 3C and Fig. 3D ). (1) being the least conserved and red (9) being the most conserved. , calculated from sedimentation velocity experiments, at three given concentrations. The predominant peak (~99%) corresponds to the homodimeric species.
VapC20 exists as a homodimer in solution
population (~99%) exists as a homodimer with observed S w (S) 2.31 AE 0.02 at a frictional ratio of 1.48 AE 0.01 (Fig. 4C) . To investigate whether other VapC homologs also self-associate to form homodimers, we analyzed known VapC structures using PDBePISA. The parameters obtained from this analysis, strongly suggest that VapCs form stable homodimers. The parameters used in the analysis i.e. calculated buried interface area, DG for interaction, the number of hydrogen bonds, and salt bridges for known VapC structures are given in Table 3 .
Self-association in VapC20 is critical for protein folding and activity
To understand the physiological role of dimerization in VapC20, we identified residues critical for the dimeric interface interactions and created six mutants; VapC20 G42E , VapC20 5A & 5B). The mutants were designed to disrupt the interface by either electrostatic repulsion (Gly42 to Glu, Arg64 to Glu, and Phe96 to Glu) and/ or by breaking existing stabilizing interactions (Trp45 to Ala, Trp83 to Ala, and Arg64 to Glu). All constructs were cloned in a tightly regulated arabinoseinducible pBAD/Myc-His vector. The toxicity of these mutants was analyzed by growth curve analysis ( Fig. 5B ) and dilution spotting assays (Fig. 5E ). To investigate the soluble expression of these mutants, we also created active site mutant variants of these mutants to aid overexpression and avoid toxicity (Fig. 5B) ( Fig. 5B) . The active site mutants (D5A) of all the dimeric interface mutants showed normal growth profile, suggesting the observed growth defect is the consequence of toxin activity. Surprisingly, the dimeric interface mutants which were nontoxic in our cell growth assay and spotting assay were showing good protein expression, suggesting that the nontoxic behavior was not because of poor protein expression (Fig. 5D ). On the other hand, weak expression was seen in E. coli strains overexpressing toxic mutants ( Fig. 5D upper panel) . However, active site mutant (D5A) variants of these constructs were expressing well, suggesting that the observed low expression of VapC20, VapC20
G42E
, VapC20 R64E , and VapC20
W83A
was because of toxicity of these mutants ( Fig. 5D lower panel). Also, we performed spotting assays to measure toxicity in E. coli and we observed that expression of VapC20 G42E , VapC20 R64E , and VapC20 W83A resulted in growth defects. Interestingly, overexpression of these point variants was more toxic as compared to the wild-type VapC20 (Fig. 5E ). To functionally characterize VapC20 mutants, we isolated the total RNA from the cells overexpressing the respective mutants followed by analysis on a Urea-PAGE gel (Fig. 5C ). As shown in Fig. 5C , cleavage of SRL RNA was observed in strains overexpressing VapC20, VapC20 G42E , VapC20 R64E , and VapC20 W83A , thereby suggesting that these mutants are active. To understand the oligomeric status of the dimeric interface mutants, we created these mutants in the D5A background to improve protein expression and expressed in the soluble form (Fig. 6 ). The remaining two nontoxic constructs, VapC20 G42E,W45A,D5A and VapC20 F96E,D5A , expressed in the insoluble fraction suggesting the loss in toxicity was the consequence of misfolding. We observed that VapC20 G42E,D5A and VapC20 W83A,D5A had poor solubility as aggregates were formed at higher concentrations. Analytical gel filtration profile of the dimeric interface mutants (VapC20 D5A,W83A and VapC20 D5A,R64E ) showed similar or higher molecular weight oligomers as all elution peaks were observed at similar or lower elution volumes compared to VapC20 (Data not shown). Since we did not find monomeric species of VapC20 or dimeric interface mutants in solution and the fact that the nontoxic dimeric interface mutants were misfolded, so we propose that the association of two monomers is critical for protein folding and activity. These results also suggest that VapC20 forms an obligate homodimer.
VapB20 is a homodimer in solution
VapB20 consists of two domains, N-terminal (residue range~1-40) DNA-binding domain, and a C-terminal (residue range~45 to C-terminal) toxin-binding domain (Fig. 7A) . Psipred analysis of VapB20 predicts the presence of a ribbon-helix-helix structural motif in the N-terminal domain (Fig. 7A) . Structural studies have shown that the N-terminal domain self-associates to form functional DNA-binding domain [16, 27, 29] . To investigate the oligomeric state of VapB20 in solution, we performed AUC experiments. The results obtained suggest a homodimeric population of~86% with S w (S) value was 1.57 AE 0.01 at a frictional ratio of 1.65 AE 0.01 (Fig. 7B) . The remaining species belong to the higher order oligomers, and we did not observe any signal corresponding to the monomeric form of VapB20. A higher frictional ratio of 1.65 indicates that VapB20 is an elongated molecule. The Psipred prediction suggests that C-terminal region of VapB20 is highly unstructured with a small helix in the middle part which might play a role in lateral inhibition of VapC20 [27] . Also, the pseudo-palindromic protein motif in VapB proteins implicated in neutralizing both active sites in cognate dimeric VapC is absent in VapB20 [27] . In a recent report, comprehensive analysis of VapBC complexes suggested that VapBs may also self-associate to form homodimers which is in agreement with our experimental data [28] . 
VapBC20 forms a stable complex with nanomolar range affinity
VapBC family of proteins from several bacterial species have been structurally and functionally characterized [16, [25] [26] [27] 29, 36, 39] . But, the affinity and the kinetic parameters for VapBC interactions have not been reported yet. We performed SPR experiments to study the kinetic parameters of the VapBC20 proteinprotein interactions. We show that VapB20 and VapC20 form a stable complex having nanomolar range affinity with K D of about 11 nM at 25°C (Fig. 7C) . SPR data suggest high association rate (k on = 2.2e 5 M
À1 Ás
À1
) and very low dissociation rate (k off = 2.53e À3 Ás À1 ) for this complex. Intracellularly, both antitoxin and toxin are cotranscribed; hence rapid association and slow dissociation are advantageous to negate the toxin activity under normal growth conditions.
VapB20 and VapC20 homodimers interact to form a concentration-dependent heterotetramer and heterooctamer
Above results demonstrate that both VapB20 and VapC20 independently form a homodimer in solution.
Since VapBCs reportedly interact to form heterooctameric species so, we were interested in resolving the intermediates, if any, formed during the formation of this complex. Though we could purify both VapB20 and VapC20 individually, mixing these proteins resulted in visible precipitation. So, we carried out AUC experiments using purified VapBC20 complex. Affinity purified VapBC20 complex was further subjected to gel filtration chromatography and AUC experiments were performed at three different protein concentrations i.e. 7 lM, 14 lM, and 28 lM (Fig. 7D ).
In the AUC experiments, we observed two major populations, one corresponding to the molecular weight of 42.3 AE 1.2 kDa and another of 95.5 AE 0.78 kDa, corresponding to the heterotetramer (VapB 2 C 2 ) and heterooctamer (VapB 4 C 4 ) species. We were able to resolve heterotetramer, an intermediate species, involved in the formation of heterooctamer in solution. The increase in the population of the heterooctameric species with the increasing concentration of the VapBC complex also suggests that transition of heterotetramer to heterooctamer is concentration-dependent (tabulated in Fig. 7D ). The parameters derived from the AUC experiments are summarized in the Table 4 .
Discussion
Persistence is one of the strategies employed by bacteria to manage stress by suspending growth and poses a challenge in treating various diseases. TA systems have gained importance as they are implicated in bacterial persistence and reportedly play an important role in virulence and pathogenesis [1, 2, 4, 11, 12] . Among several TA modules, VapBC has gained importance due to their abundance in pathogenic bacteria. In the present study, we structurally characterized VapC20 and investigated the role of self-association in the VapC20 activity and VapBC20 complex assembly.
Crystal structure analysis suggested that VapC20 forms a homodimer. This observation was further confirmed by in solution studies using AUC experiments. Based on our study and structural analyses of other VapC toxins, we propose that VapC toxins self-associate to form homodimers. In S. enterica VapC, Winther et al. [32] have shown that dissociation of toxin dimer into monomers induces TA operon. They generated mutations in the dimeric interface and found that the stabilized VapC monomers (dimeric interface mutants) lead to the induction of TA expression as a consequence of conditional cooperativity. While, studying the oligomeric state of VapBC20, we found that VapBC20 exists in two distinct oligomeric states in solution, i.e. heterotetramer and heterooctamer. The existence of heterotetramer has been reported earlier in the crystal structure of Mtb VapBC15 [26] . However, in the published heterotetrameric crystal structure the N-terminal oligomerization domain could not be resolved in the electron density, and the C-terminal domains of the antitoxin were interacting with a toxin dimer. It may be a reason why heterooctameric assembly was not observed in the crystal structure of [27] . However, they could not observe stable and distinct heterotetramer species in the crystal structures or analytical gel filtration experiments as these experiments were performed at the higher concentrations. To investigate the possibility of conditional cooperativity, as proposed by Winther et al. [32] , we performed AUC experiments where an increasing concentration of VapC20 was mixed to the preformed heterooctamer complex. Our data suggest that, in the case of VapBC20, high T/A ratio did not significantly disrupt the preformed heterooctamer (Fig. 7E) . We also attempted to obtain monomeric VapC20 by creating point mutations at the hotspot of the dimeric interface, as monomer stabilization has been proposed to anticipate conditional cooperativity [32] . However, attempts to create the structure-guided monomeric variant of VapC20 were unsuccessful. Interestingly, all the mutants that were nontoxic expressed in the insoluble fraction, suggesting folding defect as a consequence of the inability to selfassociate to attain native folded state. While the toxic mutants which were cleaving the SRL at the same position as the wild-type and having the same or higher oligomeric state(s) as that of VapC20. These results show that VapCs possibly form obligate dimers and self-association is critical for their folding. We also believe that self-association might play a role in substrate recognition and antitoxin binding as both monomers in the VapC20 form a long continuous channel for substrate/antitoxin binding. In the light of previous reports and our results, we propose a plausible model where VapC and VapB both exist as homodimers and upon interaction they first form a heterotetramer which further associates to form a concentrationdependent functional heterooctamer (Fig. 8) . Toxin dimerization also acts as a platform for assembling antitoxins and bridging two DNA-binding motifs to a distance where they can recognize two distinct binding sites in the promoter element and repress self-expression [27] (Fig. 8) . There are no reports on the kinetic parameters for protein-protein interactions of any VapBC TA systems. We performed SPR studies and observed K D of~11 nM for VapB20 and VapC20 interactions. This observed K D is about ten-fold higher than the previously characterized TA/toxin-immunity complexes [40] [41] [42] . It is worth mentioning here that during SPR experiments we could possibly only observe the formation of heterotetramer since VapC was immobilized on the sensor chip.
VapCs are evolved to perform a similar function of translation inhibition via targeting different components of translation machinery like ribosomes and tRNAs. Also, redundancy in targets was observed where multiple VapC cleave common targets [20] . The molecular basis for substrate recognition/specificity in VapC toxins is poorly understood as currently there is no structural information available for any VapC-substrate complex. Based on phylogenetic analysis, Winther et al. [20] have predicted and verified potential targets of Mtb VapCs. Self-association is responsible for the formation of the active site and along with the specificity determining residues may play a role in determining substrate specificity. Gerdes's group has shown that SRL region superimposes well with the anticodon loop of the tRNAs [23] , hence we believe that subtle structural changes could dictate substrate specificity.
To summarize, we have solved the crystal structure of the SRL cleaving VapC20 toxin. Our structural, biophysical, and functional studies have helped us in resolving the oligomeric states of the VapB20, VapC20, and VapBC20 complexes which led us to propose a refined model for autoregulation. Since VapBC modules have been targeted for drug discovery [36] , we believe high-resolution crystal structure of VapC20 may aid in designing inhibitors using rational drug design approach.
Material and methods
Cloning of vapB20, vapC20, and its point variants DNA regions encoding vapC20 and vapB20 genes were PCR amplified using Mtb H37Rv genomic DNA as a template. The active site mutant VapC20 D5A was created by incorporating mutated sequence in the forward primer followed by PCR amplification. Construction of VapC20
D5A
helped us in purifying large quantity of toxin in the inactive form, which was needed in the initial crystallization condition screening. VapC20 and VapC20 D5A were cloned in . These constructs were PCR amplified using pETDuet UP primer and gene-specific reverse primer carrying XhoI site, followed by digestion and insertion in NcoI/XhoI site in pBAD/Myc-His vector. All the above clones were confirmed by DNA sequencing.
Protein purification
All the recombinant proteins were expressed using E. coli strain Rosetta DE3 (Novagen). Transformed E. coli cells were plated on the plates with suitable selection marker and were incubated overnight at 37°C. A single colony was picked and inoculated into 10 mL of LB media and was grown overnight at 37°C with constant shaking at 200 r.p.m. Next day, 7.5 mL of culture was inoculated into 750 mL media in shake flask. Protein expression was induced at OD 600~0 .6 by adding 0.3 mM isopropyl b-D-1-thiogalactopyranoside and incubated for 16 hrs. at 16°C with constant shaking followed by harvesting of cells at 7000 g for 15 min at 4°C. The downstream processing was done at 4°C. Pellet was resuspended in lysis buffer (20 mM Tris pH 7.5, 250 mM NaCl and 1 mM PMSF) and subjected to lysis by sonication followed by centrifugation at 18 000 g for 45 min. All His-tagged proteins were purified using Ni-NTA (Gold Biotechnology) by following standard manufacturer's protocol. The identity of proteins was confirmed using peptide mass fingerprinting. MALDI-TOF experiments were performed using AB-SCIEX. Purity and quality of the protein samples were analyzed using SDS/ PAGE. Active toxin was purified from the VapBC20 complex. In the retrieval of active VapC20 toxin, the VapBC20 complex was subjected to in-column denaturation using a denaturing buffer (20 mM Tris pH 7.5, 250 mM NaCl and 8 M urea). The column was kept overnight in denaturing condition followed by in-column refolding using a linear gradient to reduce Urea concentration from 8 M (20 mM Tris pH 7.5, 250 mM NaCl and 8 M urea to 20 mM Tris pH 7.5 and 250 mM NaCl) to 0 M over about 80 mL. Retrieved active toxin was further purified using gel filtration chromatography through Superdex S200 15/300GL (GE Healthcare) in buffer condition (20 mM Tris pH 7.5, 250 mM NaCl and 1 mM DTT). The homogeneous population of active toxin eluted at 16.6 mL.
Crystallization and structure solution
All the purified proteins were subjected to crystallization trials using commercial screens from Hampton Research and Molecular Dimensions. High-throughput 96-well sitting-drop vapor diffusion crystallization trays were set up manually by mixing equal volumes (1.25 lL) of protein and reservoir solution. Only VapC20, VapC20
D5A
, and VapC20 D5A SeMet derivative could be crystallized in several conditions at 5 mgÁmL À1 and 8 mgÁmL À1 protein concentration. The diffraction quality crystals were obtained in 0.1 M potassium thiocyanate and 30% w/v polyethylene glycol monomethyl ether 2 K condition. Crystals appeared after the 1-day incubation at 18°C. X-ray diffraction data for VapC20 D5A SeMet derivative were collected at synchrotron beam line (k = 0.9788 A) at PX-BL21, RRCAT, Indore, India. Native VapC20 data were collected at home source (k = 1.5418 A) at 100 K. Data sets were processed using iMOSFLM [43] and scaled using SCALA [44] . The structure was solved by the Se-SAD method using Phenix.autosol module of Phenix software suite [45] . The native structure was solved using molecular replacement using VapC20 D5A structure as a search model using PHA-SER [46] . Both the structures were refined using Phenix.Refine [45] . Iterative steps of model building using COOT [47] and refinement using Phenix.Refine resulted in structures with R work /R free of 0.1712/0.1976 and 0.1747/0.2120 for VapC20 and SeMet derivative VapC20
, respectively. The structures had excellent geometry and there were no residues in the disallowed region of the Ramachandran Plot [48] .
Analytical Ultracentrifugation (AUC)
Analytical ultracentrifugation experiments were performed using Beckman-Coulter XL-A analytical ultracentrifuge equipped with TiAn50 eight hole rotor to study the oligomeric state of individual proteins and VapBC20 complex. For the sedimentation velocity experiments, two-channel epon centerpieces and quartz windows were used and, samples were run at 40 000 r.p.m at 15°C. Three different concentrations of protein samples, 7 lM, 14 lM, and 28 lM, were used in the experiments. All AUC experiments for VapB20 and VapC20 were performed in 20 mM HEPES pH 8.0, 150 mM NaCl while for the complex 20 mM HEPES pH 8.0, 250 mM NaCl was used. In addition, 1 mM DTT was kept in the buffers for VapC20 and VapBC20 samples. Absorbance scans were performed at 280 nm wavelength and data were collected after every 3 min interval. Data were fit using continuous distribution c(s) model in SEDFIT [49] . Solvent density and the solvent viscosity at specific temperature were calculated using SEDNTERP [50] .
Surface Plasmon Resonance (SPR)
To measure the kinetics of VapC20 and VapB20 interactions, SPR experiments were performed using Biacore 3000 (GE Healthcare). VapC20 was diluted to 2 lM concentration in 20 mM sodium acetate (pH 5.5) and immobilization was done on CM5 sensor chip up to 540 response unit (RU). Running buffer (10 mM HEPES pH 7.5, 150 mM NaCl) was filter sterilized and degassed, and experiments were performed at 25°C with a continuous flow rate of 20 lLÁmin À1 . For kinetic studies, association and dissociation were observed for 300 s and 500 s, respectively. Six different increasing concentrations of the analyte, VapB20, were injected and each experiment was repeated at least twice. The surface was regenerated by injecting multiple pulses (3-5) of 5 lL of 10 mM NaOH at a flow rate of 5 lLÁmin À1 until RU came back to baseline. Sensorgrams were analyzed using BIA evaluation software 3.0 using 1 : 1 langmuir binding model with drifting baseline.
Growth curve analysis and serial dilution spotting ). A single colony was picked and inoculated into 5 mL LB medium and allowed to grow overnight at 37°C with the constant shaking of 200 r.p.m. One percent inoculum of the overnight grown culture was transferred to 10 mL LB media vial. When the OD 600 reached 0.5, the inoculum was taken to set up culture with starting OD 600 of 0.05. Serial dilution of the mid-log phase cultures was prepared using normal saline and was spotted on LB agar plates (with and without L-arabinose). For the growth curve analyses, the culture was induced with 0.2% L-arabinose at OD 600 of 0.3-0.5 and growth was monitored by measuring OD 600 at the given time points. All the experiments were repeated three times.
RNA isolation and analysis
Samples were collected at specified time points and stored at À20°C. Total RNA was isolated using GeneJET RNA purification kit (Thermo scientific). Concentrations were measured using nanodrop instrument. One lg of RNA sample was prepared in formamide RNA loading dye and heated at 65°C for 10 min followed by quick chilling on ice. Samples were resolved on 6% Urea-PAGE followed by ethidium bromide staining and destained for 20 min in 1X TBE buffer. The gel was prerun for 30 min before loading samples.
Structural analysis
Analysis of crystal structures was done using PYMOL [51] and COOT [47] . Secondary structure prediction for VapB20 was carried out using Psipred [52] . The oligomeric states, interface interactions and theoretical DG calculations for the known VapC structures were calculated using PDBe-PISA online server at http://www.ebi.ac.uk/pdbe/pisa/. Structural homologs were searched using Dali server [35] .
